Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Computacenter PLC (CCC.L) Stock Analysis: Evaluating the Growth Potential Amidst a Competitive IT Landscape 3 December 2025
Bytes Technology Group PLC (BYIT.L) Stock Analysis: Unveiling a 43.62% Potential Upside 3 December 2025
Cranswick PLC (CWK.L) Stock Report: Analyzing Strong Growth Potential and a 15.89% Upside 3 December 2025
Chrysalis Investments Limited O (CHRY.L): Analyst Consensus Reveals a Strong Buy with a 20.77% Upside Potential 3 December 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video)
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Computacenter PLC (CCC.L) Stock Analysis: Evaluating the Growth Potential Amidst a Competitive IT Landscape 3 December 2025
Bytes Technology Group PLC (BYIT.L) Stock Analysis: Unveiling a 43.62% Potential Upside 3 December 2025
Cranswick PLC (CWK.L) Stock Report: Analyzing Strong Growth Potential and a 15.89% Upside 3 December 2025
Chrysalis Investments Limited O (CHRY.L): Analyst Consensus Reveals a Strong Buy with a 20.77% Upside Potential 3 December 2025
AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 38% Potential Upside in the Peripheral Nerve Repair Market 3 October 2025
Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a 36% Potential Upside Amidst Market Volatility 3 October 2025
Arcus Biosciences, Inc. (RCUS) Investor Outlook: Analyzing the 116% Potential Upside Amidst Robust Growth 3 October 2025
LifeMD, Inc. (LFMD) Stock Analysis: Exploring an 86% Potential Upside in Telehealth Innovation 3 October 2025
STAAR Surgical Company (STAA) Stock Analysis: Evaluating Market Position Amidst Revenue Challenges 3 October 2025
Enhabit, Inc. (EHAB) Investor Outlook: Navigating Potential Upside Amidst Market Challenges 3 October 2025
Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Exploring a Potential 304% Upside in the Biotech Sector 3 October 2025
Collegium Pharmaceutical (COLL) Stock Analysis: Potential 30% Upside in the Healthcare Sector 3 October 2025
REGENXBIO Inc. (RGNX) Stock Analysis: Biotechnology Innovator with 180% Potential Upside 3 October 2025
Castle Biosciences, Inc. (CSTL) Stock Analysis: Healthcare Innovator with a 60% Potential Upside 3 October 2025
Akso Health Group (AHG) Stock Analysis: Unpacking Revenue Growth Amidst Financial Challenges 3 October 2025
Xencor, Inc. (XNCR) Stock Analysis: Potential 103.89% Upside Amidst Strong Revenue Growth 3 October 2025
Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a Strong Revenue Growth and Potential 47.63% Upside 3 October 2025
Tyra Biosciences, Inc. (TYRA) Stock Analysis: Unpacking a Promising 135% Upside Potential 3 October 2025
Ardelyx, Inc. (ARDX): Investor Outlook on a Biotech Stock with Over 116% Potential Upside 3 October 2025
Trevi Therapeutics (TRVI) Stock Analysis: Exploring a Potential 115% Upside in the Biotech Sector 3 October 2025
Cogent Biosciences, Inc. (COGT) Stock Analysis: Unveiling a 42% Upside Potential Amidst Biotech Breakthroughs 3 October 2025
Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Exploring a Potential Upside of 217.03% with Strategic Developments in Biotechnology 3 October 2025
Firering Strategic Minerals Kiln Upgrades, Hydration Circuit and Untapped Margin Potential (Video) 23 September 2025
Acuity RM Group CEO David Rajakovich Unveils AI-Driven Turnaround and New Growth Strategy (Video) 19 September 2025
Manx Financial Group New Overdraft Tech Partnership with Fiinu Plc Targets UK Liquidity Crunch (Video) 18 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) 11 September 2025
Melrose Industries delivers 14% revenue growth and strong profit momentum in Q4 trading update 14 November 2025
Supermarket Income REIT acquires €1.23bn Carrefour portfolio in France at 6.6% yield 14 November 2025
Vietnam Enterprise Investments Limited sees strong Q3 earnings and domestic market support 14 November 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Lords Group Trading Share Price Tipped to Double on Positive 1H25 Results, Cavendish 19 September 2025
Windar Photonics builds momentum on H1 progress, platform enhanced for growth – Zeus Capital 16 September 2025
Finseta Pushes Forward with Strategic Growth Plans Despite Interim Setback – Shore Capital 11 September 2025
Computacenter PLC (CCC.L) Stock Analysis: Evaluating the Growth Potential Amidst a Competitive IT Landscape 3 December 2025
Bytes Technology Group PLC (BYIT.L) Stock Analysis: Unveiling a 43.62% Potential Upside 3 December 2025
Cranswick PLC (CWK.L) Stock Report: Analyzing Strong Growth Potential and a 15.89% Upside 3 December 2025
Chrysalis Investments Limited O (CHRY.L): Analyst Consensus Reveals a Strong Buy with a 20.77% Upside Potential 3 December 2025
